Table 8. Effect of Daily Administration of F.A (400 mg/kg) for 7 Days on Oxidative Stress Biomarkers^a.

oxidative stress markers	treatment groups	heart	liver	kidney	spleen
SOD (μg/mg of tissue protein)	C.G	4.16 ± 0.064	0.966 ± 0.021	5.664 ± 0.055	9.882 ± 0.069
	furosemide (15 mg/kg)	22.54 ± 0.303***	0.984 ± 0.039	5.052 ± 0.099**	6.758 ± 0.108***
	F.A (400 mg/kg)	24.64 ± 0.232***	0.948 ± 0.024	6.758 ± 0.108***	12.58 ± 0.091***
NO (μg/mg of tissue protein)	C.G	26.26 ± 0.422	2.79 ± 0.037	9.38 ± 0.027***	39.18 ± 0.108
	furosemide (15 mg/kg)	36.45 ± 0.33***	3.32 ± 0.044	19.75 ± 0.85***	34.51 ± 1.039***
	F.A (400 mg/kg)	36.33 ± 0.33***	3.88 ± 0.031	18.64 ± 0.624***	46.71 ± 0.626***
GSH (μg/mg of tissue protein)	C.G	54.26 ± 0.58	3.64 ± 0.058	20.14 ± 0.59	69.38 ± 0.87
	furosemide (15 mg/kg)	41.95 ± 0.57***	4.54 ± 0.24	26.14 ± 0.59***	45.37 ± 0.31***
	F.A (400 mg/kg)	46.14 ± 0.59***	6.86 ± 0.10***	28.76 ± 0.14***	87.55 ± 0.23***
MDA (μmol/mg of tissue protein)	C.G	0.95 ± 0.012	0.14 ± 0.017	1.20 ± 0.14	2.07 ± 0.06
	furosemide (15 mg/kg)	0.94 ± 0.023	0.14 ± 0.009	0.907 ± 0.022**	1.55 ± 0.020***
	F.A (400 mg/kg)	0.85 ± 0.023	0.13 ± 0.023	0.633 ± 0.012***	1.86 ± 0.009*

^aAll of the results are shown as mean ± SEM, whereas ** P < 0.01 and *** P < 0.001 when compared to the control group. All data are subjected to two-way ANOVA followed by Bonferroni’s post-test.